116 related articles for article (PubMed ID: 15207635)
1. Differential regulation of human immunodeficiency virus type 2 and simian immunodeficiency virus promoter activity.
Hiebenthal-Millow K; Pöhlmann S; Münch J; Kirchhoff F
Virology; 2004 Jul; 324(2):501-9. PubMed ID: 15207635
[TBL] [Abstract][Full Text] [Related]
2. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication.
Hiebenthal-Millow K; Kirchhoff F
Virology; 2002 Jan; 292(1):169-75. PubMed ID: 11878920
[TBL] [Abstract][Full Text] [Related]
3. Dox-dependent SIVmac with tetracycline-inducible promoter in the U3 promoter region.
Xiao Y; Kuwata T; Miura T; Hayami M; Shida H
Virology; 2000 Apr; 269(2):268-75. PubMed ID: 10753705
[TBL] [Abstract][Full Text] [Related]
4. HIV genome transcription induced by polyoma virus middle T antigen through both enhancer- and promoter-dependent LTR activation.
Jacqué JM; Vlach J; Virelizier JL; Garcia A
C R Acad Sci III; 1995 Dec; 318(12):1227-32. PubMed ID: 8745637
[TBL] [Abstract][Full Text] [Related]
5. Sequence elements downstream of the human immunodeficiency virus type 1 long terminal repeat are required for efficient viral gene transcription.
Liang C; Li X; Quan Y; Laughrea M; Kleiman L; Hiscott J; Wainberg MA
J Mol Biol; 1997 Sep; 272(2):167-77. PubMed ID: 9299345
[TBL] [Abstract][Full Text] [Related]
6. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
[TBL] [Abstract][Full Text] [Related]
7. Sequences just upstream of the simian immunodeficiency virus core enhancer allow efficient replication in the absence of NF-kappaB and Sp1 binding elements.
Pöhlmann S; Flöss S; Ilyinskii PO; Stamminger T; Kirchhoff F
J Virol; 1998 Jul; 72(7):5589-98. PubMed ID: 9621017
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.
Bentley K; Deacon N; Sonza S; Zeichner S; Churchill M
Arch Virol; 2004 Dec; 149(12):2277-94. PubMed ID: 15338321
[TBL] [Abstract][Full Text] [Related]
9. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
10. Retinoic acid inhibits both the basal activity and phorbol ester-mediated activation of the HIV long terminal repeat promoter.
Towers G; Harris J; Lang G; Collins MK; Latchman DS
AIDS; 1995 Feb; 9(2):129-36. PubMed ID: 7718183
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
[TBL] [Abstract][Full Text] [Related]
12. NF kappa B upstream regulatory sequences of the HIV-1 LTR are involved in the inhibition of HIV-1 promoter activity by the NS proteins of autonomous parvoviruses H-1 and MVMp.
Faisst SR; Faisst S; Grangette C; Schlehofer JR; Rommelaere J
Virology; 1993 Dec; 197(2):770-3. PubMed ID: 8249299
[TBL] [Abstract][Full Text] [Related]
13. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1.
Naghavi MH; Schwartz S; Sönnerborg A; Vahlne A
AIDS Res Hum Retroviruses; 1999 Sep; 15(14):1293-303. PubMed ID: 10505678
[TBL] [Abstract][Full Text] [Related]
14. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
Zhao C; Chen Y; Park J; Kim JB; Tang H
Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
[TBL] [Abstract][Full Text] [Related]
16. Genetic Variability of Long Terminal Repeat Region between HIV-2 Groups Impacts Transcriptional Activity.
Le Hingrat Q; Visseaux B; Bertine M; Chauveau L; Schwartz O; Collin F; Damond F; Matheron S; Descamps D; Charpentier C
J Virol; 2020 Mar; 94(7):. PubMed ID: 31915276
[TBL] [Abstract][Full Text] [Related]
17. Abundant authentic MMTV-Env production from a recombinant provirus lacking the major LTR promoter.
Rungaldier S; Nejad Asl SB; Günzburg WH; Salmons B; Rouault F
Virology; 2005 Nov; 342(2):201-14. PubMed ID: 16140354
[TBL] [Abstract][Full Text] [Related]
18. Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.
Münch J; Schindler M; Wildum S; Rücker E; Bailer N; Knoop V; Novembre FJ; Kirchhoff F
J Virol; 2005 Aug; 79(16):10547-60. PubMed ID: 16051847
[TBL] [Abstract][Full Text] [Related]
19. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model.
Barber SA; Gama L; Dudaronek JM; Voelker T; Tarwater PM; Clements JE
J Infect Dis; 2006 Apr; 193(7):963-70. PubMed ID: 16518758
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB-repressing factor inhibits elongation of human immunodeficiency virus type 1 transcription by DRB sensitivity-inducing factor.
Dreikhausen U; Hiebenthal-Millow K; Bartels M; Resch K; Nourbakhsh M
Mol Cell Biol; 2005 Sep; 25(17):7473-83. PubMed ID: 16107696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
